Blood group and ovarian hyperstimulation syndrome

Fertility and Sterility

Volumn 93, Issue 1, 2010, Pages 270-271

  Bellver, José ^a   Ferrando, Marcos ^a   Garrido, Nicolás ^a   Pellicer, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD GROUP; EMBRYO TRANSFER; HUMAN; INFERTILITY THERAPY; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RISK FACTOR;

ABO BLOOD-GROUP SYSTEM; FEMALE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 72749109611     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.07.983     Document Type: Article

References (11)

1. Shahin A.Y. The problem of IVF cost in developing countries: has natural cycle IVF a place?. Reprod Biomed Online 15 (2007) 51-56
2. Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 90 (2008) S188-S193
3. Alvarez C., Martí-Bonmatí L., Novella-Maestre E., Sanz R., Gómez R., Fernández-Sánchez M., et al. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 92 (2007) 2931-2937
4. Mathur R., Kailasam C., and Jenkins J. Review of the evidence base strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil (Camb) 10 (2007) 75-85
5. Mathur R.S., Akande A.V., Keay S.D., Hunt L.P., and Jenkins J.M. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 73 (2000) 901-907
6. Papanikolau E.G., Tournaye H., Verpoest W., Camus M., Vernaeve V., Van Steirteghem A., et al. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod 20 (2005) 636-641
7. Binder H., Flegel W.A., Emran J., Müller A., Cupisti S., Beckmann M.W., et al. Blood group A: an overseen risk factor for early-onset ovarian hyperstimulation syndrome. Reprod Biomed Online 17 (2008) 185-189
8. ÓDonnell J., and Laffan M.A. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 11 (2001) 343-351
9. Bellver J., Muñoz E., Ballesteros A., Soares S.R., Bosch E., Simón C., et al. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Hum Reprod 18 (2003) 2283-2288
10. Golan A., Ron-El R., Herman A., Soffer Y., Weinraub Z., and Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44 (1989) 430-440
11. Soares S.R., Gómez R., Simón C., García-Velasco J.A., and Pellicer A. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update 14 (2008) 321-333